Stock & Company Details
GH Research PLC $GHRS
Price:
46,691,331
69M
$1.9B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Services
GHRS technical indicators
Latest GH Research PLC (GHRS) technical indicators as of 2026-07-20: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
58.21 9.7%
MACD:
1.32 4.3%
SMA 50:
$23.78 0.4%
SMA 200:
$17.27 0.4%
EMA 20:
$26.30 0.5%
Bollinger Bands:
29.86 / 23.21
Stochastic:
57.61 7.4%
ADX 14:
31.43 1.3%
ATR 14:
1.84 0.3%
CCI 20:
88.10 30.0%
OBV:
20.33M 1.0%
ROC 12:
4.20% 38.3%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
Finance Bot
Ask your questions
Start by typing a question below.
